GYRE
GYRE THERAPEUTICS, INC.
GYRE THERAPEUTICS, INC. (GYRE) has 3 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 22, 2026.
The most active filer is Chief Operating Officer Ye Weiguo with 5 filings. Insiders have net sold $288K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Ping Zhang
- Employees:579
- HQ:San Diego, CA, US
- IPO:2006-04-12
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$288K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$636.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Operating Officer | Sale | 3,000 | $18K | Jun 22 | SEC ↗ | |
| Chief Operating Officer | Sale | 5,000 | $31K | Jun 22 | SEC ↗ | |
| Chief Operating Officer | Sale | 3,000 | $19K | Jun 22 | SEC ↗ | |
Ye WeiguoFirst filing | Chief Operating Officer | Sale | 9,400 | $58K | May 22 | SEC ↗ |
Ye WeiguoFirst filing | Chief Operating Officer | Sale | 12,820 | $79K | May 22 | SEC ↗ |
Luo YingFirst filing | Chief Executive Officer | Sale | 179 | $1K | May 8 | SEC ↗ |
Luo YingFirst filing | Chief Executive Officer | Sale | 10,136 | $81K | May 8 | SEC ↗ |
Related companies
GYRE THERAPEUTICS, INC. is in the Healthcare sector.